Patents by Inventor Shitij Kapur

Shitij Kapur has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Atypical antipsychotic agents having low affinity for the D2 receptor
    Publication number: 20090149442
    Abstract: The present invention provides novel compounds of Formula I: The invention further relates to pharmaceutical compositions comprising compounds of Formula I and to methods of using compounds of Formula I to treat neuropsychiatric disorders (e.g., psychosis, depression, schizophrenia).
    Type: Application
    Filed: January 25, 2007
    Publication date: June 11, 2009
    Inventors: Shitij Kapur, Robert McClelland
  • Atypical antipsychotic agents having low affinity for the D2 receptor
    Publication number: 20060166965
    Abstract: The present invention provides novel compounds of Formula I: The invention further relates to pharmaceutical compositions comprising compounds of Formula I and to methods of using compounds of Formula I to treat neuropsychiatric disorders (e.g., psychosis, depression, schizophrenia).
    Type: Application
    Filed: January 5, 2006
    Publication date: July 27, 2006
    Inventors: Shitij Kapur, Robert McClelland
  • Atypical antipsychotic agents having low affinity for the D2 receptor
    Publication number: 20050222121
    Abstract: The present invention provides novel compounds of Formula I: The invention further relates to pharmaceutical compositions comprising compounds of Formula I and to methods of using compounds of Formula I to treat neuropsychiatric disorders (e.g., psychosis, depression, schizophrenia).
    Type: Application
    Filed: January 10, 2005
    Publication date: October 6, 2005
    Inventors: Shitij Kapur, Robert McClelland
  • Atypical antipsychotic agents having low affinity for the D2 receptor
    Patent number: 6890919
    Abstract: The present invention provides novel compounds of Formula I: The invention further relates to pharmaceutical compositions comprising compounds of Formula I and to methods of using compounds of Formula I to treat neuropsychiatric disorders (e.g., psychosis, depression, schizophrenia).
    Type: Grant
    Filed: June 25, 2002
    Date of Patent: May 10, 2005
    Inventors: Shitij Kapur, Robert McClelland
  • Atypical antipsychotic agents having low affinity for the D2 Receptor
    Publication number: 20030135042
    Abstract: The present invention provides novel compounds of Formula I: 1
    Type: Application
    Filed: June 25, 2002
    Publication date: July 17, 2003
    Applicant: NeuroMolecular, Inc.
    Inventors: Shitij Kapur, Robert McClelland